Ways2Capital is one of the leading research house across the globe. The company basically provides recommendations for stocks cash & F&O traded in NSE & BSE,commodities including bullions, metals and agro commodities traded in MCX & NCDEX.
4. NSE WEEKLY NEWS UPDATE
✍ FIIs inflow reaches Rs 21,000cr so far in January
Overseas investors have pumped in a staggering over Rs 21,000 crore in Indian capital markets
since the beginning of the month owing to easing inflation and rate cut by Reserve Bank of
India (RBI). Foreign Institutional Investors (FIIs) have bought shares worth Rs 5,992 crore
($977 million) till January 23, while bought debt worth Rs 15,336 crore ($2.5 billion) taking
the total investment to Rs 21,328 crore ($3.45 billion), latest data with Central Depository
Services Ltd (CDSL) showed.
✍ Pipavav Defense stock crashes 12%
Pipavav Defense and Offshore Engineering stock plunged 12% at Rs. 60.The stock has hit a
high of Rs. 65 and a low of Rs. 60.Total traded quantity on the counter stood at over 19.98 lk
shares.Anil Ambani, Chairman, Reliance ADAG Group, says he will leave no stone unturned to
make Pipavav Defence and Offshore Engineering India’s biggest defence manufacturer. Anil
Ambani, met with employees of Pipavav Defence and Offshore Engineering workers besides
meeting Nikhil Gandhi of the Pipavav Group.Pipavav Defence has one of the world's largest
Infrastructure facilities - spread over 841 acres of land on the West Coast of India (Gujarat),
Gulf of Cambay, with 210 acres of fully developed water front land and 250 acres developed
for shipbuilding.
✍ Sun Pharma-Ranbaxy merger receives HC nod
The Punjab & Haryana High Court has given approval to the merger of Sun Pharma and
Ranbaxy. After the deal, Sun Pharma will become the world’s fifth-largest generic drug maker,
says report.Ranbaxy Laboratories Ltd has announced that the High Court of Punjab & Haryana
has orally pronounced the Order on March 09, 2015, approving the Scheme of Arrangement
involving merger of Ranbaxy Laboratories Ltd. with Sun Pharmaceutical Industries Ltd. under
Sections 391 to 394, Sections 78 and 100 of the Companies Act. 1956 and Section 52 of the
Companies Act, 2013.Under the deal, Ranbaxy shareholders will get 0.8 Sun Pharma share for
each Ranbaxy share held.
✍ Suzlon Energy plans to sell forging and foundry company
Suzlon Energy is reportedly planning to sell its forging and foundry company. The company
5. invested Rs 1,000 crore in forging and foundry company. "We are in the process of divesting
stake in our forging company, SE Forge. If and when we get good valuation, we will exit as
forging and foundry are not our core business," Suzlon Chairman Tulsi Tanti reported.The
company is focused on profitably rationalising all aspects of our overall business and plans to
sell, which comprise 3-4 manufacturing units, senior company executive reported.
✍ India's growth will be stronger than the average global rate
Moody's in a statement reportedly said India's growth will be stronger than the average global
rate.Moody's also predicted a robust growth for India.India's budget prioritises growth over
deficit reduction which will increase the needs for new sources of long- term funding, Moody's
reported."While the government has injected its own capital to support various reform
initiatives, securitisation could play a significant role by providing funds to finance
development projects," Georgina Lee, assistant vice president at Moody's quoted.
✍ BHEL commissions supercritical Thermal unit in Bihar; stock down 2%
Shares of Bharat Heavy Electricals Ltd were trading down 2% at Rs. 265 on BSE today.The
stock opened at Rs. 269 as against the previous close of Rs. 270 on BSE. It has hit a high of Rs.
269 and a low of Rs. 263 on BSE today.Total traded quantity on the counter stood at over 1.32
lk shares on BSE.
✍ Bank shares tumble across the board
Banking shares are trading on a weak note this morning on account of profit-taking ahead of
IIP data this Thursday. Also fears of the US Federal Reserve hiking interest rates
sooner-than-later have dampened the sentiment in the market.The CNX Bank Nifty index has
dropped 2 per cent at 19,348. Axis Bank is the top loser, down 3 per cent at Rs. 598. Bank of
Baroda plunged over 2.5 per cent at Rs. 179.Canara Bank, ICICI Bank and Kotak Bank have
slipped 2.4 per cent each at Rs. 414, Rs. 339 and Rs. 1,379, respectively.
Bank of India and Punjab National Bank have tumbled over 2 per cent each at Rs. 224 and Rs.
160, respectively.Federal Bank, Yes Bank, IndusInd Bank, HDFC Bank and SBI are the other
significant losers.
6. ✍ IOC, ONGC, OIL among 5 companies named by US administration for Iran ties
ONGC,
IOC and OIL are among the five global companies named by the US administration for having
energy ties with Iran, according to reports.A report stated that US government accountability
office named Oil and Natural Gas Corp (ONGC), Indian Oil Corp (IOC) and Oil India Ltd
(OIL) along with China's CNPC and Sinopec.The three firms have been named for their stake
in the Farsi offshore block in Iran, says the report.IOC's 2013-14 annual report stated that the
firm has a 40 per cent participating share in the Farsi Block Project. ONGC holds 40% in Farsi
through its overseas investment arm, ONGC Videsh Ltd. An earlier report had stated that the
Farsi block is estimated to have reserves of up to 21.68 trillion cu. ft (tcf), with recoverable
reserves of around 12.8 tcf. Developing the gas field, together with the construction of a
liquefied natural gas terminal to transport the gas, was estimated to require an investment of
$8-9 billion (approximately Rs35,000-40,000 crore), in 2010.
✍ FPIs buy net shares worth Rs. 31,250 crore till Mar 5
The net foreign fund inflows into Indian capital markets stood at $11.08 billion (over Rs.
68,552 crore) till March 5 this year, according to the data compiled by the Central Depository
Services Ltd (CDSL).The Foreign portfolio investors (FPIs) bought shares worth a net amount
of Rs. 31,256 crore till March 5 this year, while in the debt segment, their net inflows stand at
Rs. 37,296 crore, taking the total to Rs. 68,552 crore, the data indicated.Overseas investors
reported a net inflow of Rs. 24,563 crore February, while the same stood at Rs. 33,688 crore in
the month of January. According to market experts, inflow of funds is expected to continue in
the coming months, as Finance Minister Arun Jaitley announced a number of measures to
attract overseas investment in the country in his Union Budget.
✍ GMR Infrastructure stock down 2%
Shares of GMR Infrastructure was down 2% at Rs. 17.40, after the company said that its Rs.
1,400 crore rights issue will open on March 24. The stock has hit a high of Rs. 17.75 and a low
of Rs. 17.35.Total traded quantity on the counter stood at over 10.92 lk shares.
The closing date for the rights issue is April 8, 2015."The Management Committee of the Board
of Directors of the Company has approved and adopted the Letter of Offer (LOF) and issue
schedule, for the issue of equity shares having face value of Re 1 each by the company on a
rights basis to its existing shareholders," GMR Infrastructure informed BSE. The closing date
for the rights issue is April 8, 2015.
7. ✍ Satyam case verdict deferred till April 9 by CBI court
The judgement for the multi-crore accounting fraud in the erstwhile Satyam Computer Services
Limited (SCSL) has been deferred to April 9th by a special CBI court today.
The decision on the case was expected today, as during the last hearing on December 23, 2014,
Special Judge BVLN Chakravarthi, while citing voluminous documents of the case, had said he
would pronounce the verdict on March 9, according to media reports.The Satyam case is
country's biggest accouting fraud involving the firm's founder B. Ramalinga Raju, where he
allegedly confessed to manipulating his company's account books and inflating profits over
many years. Besides Raju, his brother B Rama Raju, former chief financial officer Vadlamani
Srinivas, former PwC auditors Subramani Gopalakrishnan and T Srinivas, Raju's another
brother B Suryanarayana Raju, former employees G Ramakrishna, D Venkatpathi Raju and Ch
Srisailam and Satyam's former internal chief auditor VS Prabhakar Gupta are also accused in
the high profile case.
In February 2009, the CBI took charge of the investigation and alleged that the fraud caused
Rs. 14,000 crore loss to the shareholders of Satyam. -
✍ SPARC stock zooms 14%
SPARC stock surged 14% at Rs. 539 after company announced USFDA approval of ELEPSIA
XR.The stock has hit a high of Rs. 543 and a low of Rs. 475.Total traded quantity on the
counter stood at over 8.38 lk shares Sun Pharma’s market cap zoomed by Rs. 26,162.98 crore
to Rs. 2,14,845.98 crore, clocking the biggest gain among the Top- 10 Sensex firms. Sun
Pharma’s promoter Dilip Shanghvi recently overtook Mukesh Ambani as India's richest person,
with shares of Sun Pharma and Sun Pharma Advanced Research Company, or Sparc (Sun
Pharma's research and development arm), closing at record highs.
✍ Man Infraconstruction gains 4% on order win
Shares of Man Infraconstruction Ltd were trading up 4.3% at Rs.47.30 on BSE today. The stock
opened at Rs. 45.35 as against the previous close of Rs.45 on BSE. It has hit a high of Rs. 47.40
and a low of Rs. 45 on BSE today. The company has received a new order worth Rs.96.8 crore
approximately for construction of civil works and approach road works for Residential
development project 'Godrej City- Phase I' at Panvel from Godrej Group.Total traded quantity
8. on the counter stood at over 4.11 lk shares on BSE.
✍ TCS stock down 2%
TCS stock has cooled by over 2% and is trading at Rs. 2654 as the company is expected to
clock revenues similar to last year. The stock hit a high of Rs. 2657 and a low of Rs. 2611.Total
traded quantity on the counter stood at over 0.29 lk shares.Speaking to analysts, Rajesh
Gopinath, Chief Financial Officer, TCS, says he expects to see some degrowth in the energy
sector, which will take a while to stabilize.Europe is expected to grow better than average, says
TCS.Tata Consultancy Services has recently been recognized as the fastest growing IT Services
brand globally over the last five years by Brand Finance, the world’s leading brand valuation
firm. In the five year period 2010-2015, TCS emerged as the clear growth leader in the
industry, increasing its brand value from US $2.3 billion to US $8.7 billion, while retaining the
industry’s highest brand strength rating of ‘AA+’. It was also recognized as one of the top four
global brands in IT Services for the fourth year in a row, cementing its position in the highest
league of the industry.
✍ ConCor rallies 9% after RBI nod for hike in FII limit
Container Corporation (ConCor) surged 9% to Rs.1,623 following Reserve Bank of India (RBI)
approval for higher FII investment limit in the company.According to a release issued by the
RBI, the central bank last week notified that FII/NRI/FPI can invest up to 34 per cent of the
paid up capital of Container Corporation of India. SIAM predicts 3-4% growth of 4-wheeler
market in FY16 Society of Indian Automobile Manufacturers has predicted that 4-wheeler
market will grow at 3-4% in FY16.The industry watchdog has also shared its outlook on the
2-wheelers market and said that it will continue to grow at 8-10% in FY16. It is also expected
that growth in FY16 will be better than growth in FY15.However, SIAM had a word of caution
that if interest rates improve, FY16 growth will be much better. Sales of passenger vehicles in
the domestic market grew by just 3.67 per cent in the April-December period this fiscal at
18,94,932 units as against 18,27,866 units in year-ago period.The industry saw a mixed bag
result for the sale of vehicles in February 2015. The big five of the auto industry - Mahindra &
Mahindra, Maruti Suzuki, Hyundai Motor India, Honda Cars India and Tata Motors posted
decent gains on YoY. For two wheelers, February was a tough month with only the scooter
segment showing growth signs. Hero MotoCorpregistered a fall of 3.85 percent YoY in Feb
2015, while Honda Motorcycle witnessed a marginal drop of 2.25% in its motorcycle sales.
9. This Document has been prepared by Ways2Capital (A Division of High Brow Market
Research Investment Advisory Pvt Ltd). The information, analysis and estimates contained
herein are based on Ways2Capital Equity/Commodities Research assessment and have been
obtained from sources believed to be reliable. This document is meant for the use of the
intended recipient only.
This document, at best, represents Ways2Capital Equity/Commodities Research opinion and is
meant for general information only. Ways2Capital Equity/Commodities Research, its directors,
officers or employees shall not in any way to be responsible for the contents stated herein.
Ways2Capital Equity/Commodities Research expressly disclaims any and all liabilities that
may arise from information, errors or omissions in this connection. This document is not to be
considered as an offer to sell or a solicitation to buy any securities or commodities.
All information, levels & recommendations provided above are given on the basis of technical
& fundamental research done by the panel of expert of Ways2Capital but we do not accept any
liability for errors of opinion. People surfing through the website have right to opt the product
services of their own choices.
Any investment in commodity market bears risk, company will not be liable for any loss done
on these recommendations. These levels do not necessarily indicate future price moment.
Company holds the right to alter the information without any further notice. Any browsing
through website means acceptance of disclaimer.